We do not recommend sourcing your GLP-1 from compounding pharmacies as they are not regulated by the FDA and the safety and efficacy of their product has not been tested. Side effects: Nausea, vomiting, and other stomach issues can make sticking with the treatment tough
For the past 7 years, pharmaceuticals that work as glucagon-like peptide 1 (GLP-1) receptor agonists have dominated the weight-loss and diabetes markets
The nausea, the fatigue, the gastrointestinal distress, these typically correlate with the concentration peak, not the average level
Understanding your baseline thyroid biomarkers, genetic predispositions in GLP-1 metabolism, and how your body may respond to treatment allows you and your provider to make safer, more informed decisions about whether compounded semaglutide or alternative peptides align with your health profile